Cortical Excitability in Neuropathic Pain: Investigating the combined effects of pregabalin and repetitive transcranial magnetic stimulation

Trial Profile

Cortical Excitability in Neuropathic Pain: Investigating the combined effects of pregabalin and repetitive transcranial magnetic stimulation

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Neuropathic pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Dec 2015 Planned End Date changed from 30 Nov 2015 to 28 Nov 2015 according to United Kingdom Clinical Research Network.
    • 10 Dec 2015 Status changed from recruiting to active, no longer recruiting according to United Kingdom Clinical Research Network.
    • 01 Dec 2015 Accrual to date is 225% according to United Kingdom Clinical Research Network
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top